{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/267238942"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In addition to disclosing its financial results determined in accordance with GAAP, Mylan is disclosing non-GAAP results that exclude items such as amortization expense and other costs directly associated with the acquisitions as well as certain other expense and revenue items in order to supplement investors' and other readers' understanding and assessment of the company's financial performance b" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "bio-medicine.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/165849502"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/267238942" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/70389572"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/267238942"] } } }
